Gary A. Ulaner

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 752 citations · Full text

Tumor Biology, Oncology, Medicine +8

Ado-Trastuzumab Emtansine for Patients With <i>HER2</i>-Mutant Lung Cancers: Results From a Phase II Basket Trial

Bob T. Li, Ronglai Shen, Darren J. Buonocore et al. · Journal of Clinical Oncology · 2018 · 541 citations

Tumor Biology, Partial Response Rate, Medicine +14

Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.

Gary A. Ulaner, Ji‐Fan Hu, Thanh Vu et al. · PubMed · 1998 · 501 citations

Telomere Lengths, Genetics, Telomerase Activity +17

Vemurafenib for <i>BRAF</i> V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

Eli L. Diamond, Vivek Subbiah, A. Craig Lockhart et al. · JAMA Oncology · 2017 · 395 citations · Full text

Efficacy of MEK inhibition in patients with histiocytic neoplasms

Eli L. Diamond, Benjamin H. Durham, Gary A. Ulaner et al. · Nature · 2019 · 370 citations

Medicine, Malignant Blood Disorder, Histopathology +4